These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20391486)

  • 41. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up.
    Bertoli AM; Fernández M; Calvo-Alén J; Vilá LM; Sanchez ML; Reveille JD; Alarcón GS;
    Lupus; 2006; 15(1):19-25. PubMed ID: 16482741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Catoggio LJ; Drenkard C; Sarano J; Berbotto GA; Borba EF; Sato EI; Tavares Brenol JC; Uribe O; Ramirez Gómez LA; Guibert-Toledano M; Massardo L; Cardiel MH; Silveira LH; Chacón-Diaz R; Alarcón GS; Pons-Estel BA;
    Ann Rheum Dis; 2017 Dec; 76(12):2071-2074. PubMed ID: 28939626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected].
    Andrade R; Sanchez ML; Alarcón GS; Fessler BJ; Fernández M; Bertoli AM; Apte M; Vilá LM; Arango AM; Reveille JD;
    Clin Exp Rheumatol; 2008; 26(2):268-74. PubMed ID: 18565248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.
    Pons-Estel GJ; Alarcón GS; Burgos PI; Hachuel L; Boggio G; Wojdyla D; Nieto R; Alvarellos A; Catoggio LJ; Guibert-Toledano M; Sarano J; Massardo L; Vásquez GM; Iglesias-Gamarra A; Lavras Costallat LT; Da Silva NA; Alfaro JL; Abadi I; Segami MI; Huerta G; Cardiel MH; Pons-Estel BA;
    Lupus; 2013 Aug; 22(9):899-907. PubMed ID: 23857989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability.
    Bertoli AM; Fernández M; Alarcón GS; Vilá LM; Reveille JD
    Ann Rheum Dis; 2007 Jan; 66(1):12-7. PubMed ID: 16815862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.
    Arroyo-Ávila M; Santiago-Casas Y; McGwin G; Cantor RS; Petri M; Ramsey-Goldman R; Reveille JD; Kimberly RP; Alarcón GS; Vilá LM; Brown EE
    Clin Rheumatol; 2015 Jul; 34(7):1217-23. PubMed ID: 25896533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII).
    Andrade RM; McGwin G; Alarcón GS; Sanchez ML; Bertoli AM; Fernández M; Fessler BJ; Apte M; Arango AM; Bastian HM; Vilá LM; Reveille JD;
    Rheumatology (Oxford); 2006 Nov; 45(11):1380-4. PubMed ID: 16880189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
    Fasano S; Margiotta DPE; Pierro L; Navarini L; Riccardi A; Afeltra A; Valentini G
    Clin Rheumatol; 2019 Feb; 38(2):457-463. PubMed ID: 30194649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.
    Danila MI; Pons-Estel GJ; Zhang J; Vilá LM; Reveille JD; Alarcón GS
    Rheumatology (Oxford); 2009 May; 48(5):542-5. PubMed ID: 19233884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre.
    Hill DD; Eudy AM; Egger PJ; Fu Q; Petri MA
    Lupus Sci Med; 2021 Apr; 8(1):. PubMed ID: 33832976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.
    Willis R; Seif AM; McGwin G; Martinez-Martinez LA; González EB; Dang N; Papalardo E; Liu J; Vilá LM; Reveille JD; Alarcón GS; Pierangeli SS
    Lupus; 2012 Jul; 21(8):830-5. PubMed ID: 22343096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.
    Bertoli AM; Vilá LM; Reveille JD; Alarcón GS;
    J Rheumatol; 2008 Dec; 35(12):2355-8. PubMed ID: 19004040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.
    Molad Y; Gorshtein A; Wysenbeek AJ; Guedj D; Majadla R; Weinberger A; Amit-Vazina M
    Lupus; 2002; 11(6):356-61. PubMed ID: 12139373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
    Hanly JG; Su L; Urowitz MB; Romero-Diaz J; Gordon C; Bae SC; Bernatsky S; Clarke AE; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin P; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcón GS; Fessler BJ; Manzi S; Nived O; Sturfelt GK; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Theriault C; Thompson K; Farewell V
    Arthritis Rheumatol; 2015 Jul; 67(7):1837-47. PubMed ID: 25778456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of African-American ethnicity and smoking status with total and individual damage index in systemic lupus erythematosus.
    Kallas R; Li J; Petri M
    Clin Rheumatol; 2020 Feb; 39(2):365-373. PubMed ID: 31705325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.
    Bastian HM; Roseman JM; McGwin G; Alarcón GS; Friedman AW; Fessler BJ; Baethge BA; Reveille JD;
    Lupus; 2002; 11(3):152-60. PubMed ID: 12004788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?
    Uribe AG; McGwin G; Reveille JD; Alarcón GS
    Autoimmun Rev; 2004 Jun; 3(4):321-9. PubMed ID: 15246029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry.
    Calvo-Alén J; Reveille JD; Rodríguez-Valverde V; McGwin G; Baethge BA; Friedman AW; Alarcón GS
    Lupus; 2003; 12(5):377-85. PubMed ID: 12765301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.